series-b
Stage
2017
Founded
2
Investors
About
Variant Bio leverages human genetic diversity to identify novel therapeutic targets, focusing on individuals with exceptional health-related traits to transform drug development.
Explore Variant Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.